Roxanne Nelson

A bill introduced in the Senate would allow Medicare to provide coverage for multi-cancer screening tests once they have been approved and proven to show clinical benefit.

Using early-response biomarkers in patients treated with lutetium-177 PSMA-617 can help personalize dosing intervals and potentially improve outcomes.

Cutaneous immune-related adverse events are associated with a better prognosis among patients with cancer who receive immune checkpoint inhibitors, new research suggests.

Linking hospital patients to virtual nurses via a computer screen could reduce the administrative tasks of bedside nurses -- and provide a rewarding alternative career path for some overworked nurses.

Researchers have identified biomarkers, alongside clinical risk factors, that may provide better cancer risk assessment and identify individuals who should be screened.

Despite improved survival rates and guideline recommendations, many eligible patients with metastatic Merkel cell carcinoma are not receiving immunotherapy.

Almost three quarters of survey respondents reported experiencing psychological and emotional stress or burnout associated with being a Mohs surgeon and 68% reported a musculoskeletal injury.

Certain minority populations may be at a higher risk of being prescribed opioids post-operatively, which may confer further risks of complications of chronic opioid use.

Healthcare delivery costs are rising, but there has been a lag in the increase in dermatologic procedure reimbursement rates.

There is persistent growth in eBT/SRT by a small but expanding proportion of general dermatologists.